Recent studies in healthy populations have associated IL-32 with atherogenic lipoproteins [50] and with monocyte endothelial adhesion mediated by intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), a crucial step in atherosclerosis pathogenesis. Here, IL32 is linked to atherosclerosis.